PTX 2.27% 4.3¢ prescient therapeutics limited

PTX Media related, page-1247

  1. 7,702 Posts.
    lightbulb Created with Sketch. 3260
    Is this the reason that PTX are holding off from starting our first OmniCAR clinical trial, do you think, Unique? With the way the financial markets are, it would make sense to delay the start until we can incorporate our resultant R&D technology with Thermo FIsher - to derive the cost savings by doing in-house, decentralised manufacturing ourselves using TF equipment. Its been in the back of my mind for some time.

    https://hotcopper.com.au/data/attachments/5306/5306481-831abd9dcd404eb88a02bd349f3d2ddc.jpg
    National media exposure of immunotherapy by well-known commentators, pressure from the public, cancer sufferers and oncological experts like the Prof, could certainly help our cause. Strike while the iron is hot! I think SYC needs to really hammer home how OmniCAR, CellPryme and TF's collab can make Car T trials and therapies much cheaper!

    PS: I have not been drinking (damn it)!

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
-0.001(2.27%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.5¢ 4.3¢ $17.99K 416.9K

Buyers (Bids)

No. Vol. Price($)
6 152502 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 502504 5
View Market Depth
Last trade - 15.59pm 17/05/2024 (20 minute delay) ?
Last
4.3¢
  Change
-0.001 ( 4.44 %)
Open High Low Volume
4.3¢ 4.5¢ 4.3¢ 123400
Last updated 15.57pm 17/05/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.